We present an integrated methodology for detecting, segmenting and classifying breast masses from mammograms with minimal user intervention. This is a long standing problem due to low signal-to-noise ratio in the visualisation of breast masses, combined with their large variability in terms of shape, size, appearance and location. We break the problem down into three stages: mass detection, mass segmentation, and mass classification. For the detection, we propose a cascade of deep learning methods to select hypotheses that are refined based on Bayesian optimisation. For the segmentation, we propose the use of deep structured output learning that is subsequently refined by a level set method. Finally, for the classification, we propose the use of a deep learning classifier, which is pre-trained with a regression to hand-crafted feature values and fine-tuned based on the annotations of the breast mass classification dataset. We test our proposed system on the publicly available INbreast dataset and compare the results with the current state-of-the-art methodologies. This evaluation shows that our system detects 90% of masses at 1 false positive per image, has a segmentation accuracy of around 0.85 (Dice index) on the correctly detected masses, and overall classifies masses as malignant or benign with sensitivity (Se) of 0.98 and specificity (Sp) of 0.7.
In this paper, we explore the use of deep convolution and deep belief networks as potential functions in structured prediction models for the segmentation of breast masses from mammograms. In particular, the structured prediction models are estimated with loss minimization parameter learning algorithms, representing: a) conditional random field (CRF), and b) structured support vector machine (SSVM). For the CRF model, we use the inference algorithm based on tree re-weighted belief propagation with truncated fitting training, and for the SSVM model the inference is based on graph cuts with maximum margin training. We show empirically the importance of deep learning methods in producing state-of-the-art results for both structured prediction models. In addition, we show that our methods produce results that can be considered the best results to date on DDSM-BCRP and INbreast databases. Finally, we show that the CRF model is significantly faster than SSVM, both in terms of inference and training time, which suggests an advantage of CRF models when combined with deep learning potential functions.
In this paper, we present a novel method for the segmentation of breast masses from mammograms exploring structured and deep learning. Specifically, using structured support vector machine (SSVM), we formulate a model that combines different types of potential functions, including one that classifies image regions using deep learning. Our main goal with this work is to show the accuracy and efficiency improvements that these relatively new techniques can provide for the segmentation of breast masses from mammograms. We also propose an easily reproducible quantitative analysis to assess the performance of breast mass segmentation methodologies based on widely accepted accuracy and running time measurements on public datasets, which will facilitate further comparisons for this segmentation problem. In particular, we use two publicly available datasets (DDSM-BCRP and INbreast) and propose the computation of the running time taken for the methodology to produce a mass segmentation given an input image and the use of the Dice index to quantitatively measure the segmentation accuracy. For both databases, we show that our proposed methodology produces competitive results in terms of accuracy and running time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.